GENE ONLINE|News &
Opinion
Blog

mRNA
GeneOnline’s Weekly News Highlights: Oct 30-Nov 3
2023-11-07
Moderna Launches mRNA Platform Incubator Network to Boost Australian mRNA Research
2023-11-06
Victoria Offers Grants to Accelerate mRNA-Based Therapeutics Research
2023-11-01
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
The World’s First mRNA Vaccine to Fight Against Antibiotic-Resistant Bacteria
2023-03-14
A New Phase in Drug Development: Programming the Genome
2023-03-02
Moderna, Life Edit To Develop In Vivo Gene Editing Therapies
2023-02-23
Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel
2022-05-23
Scientists Jointly Urge FDA to Evaluate T-Cell Response in Review of COVID-19 Vaccines
2022-04-27
Moderna Shares Promising Preliminary Bivalent COVID-19 Booster Results
2022-04-20
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
Was Novavax’s Vaccine Rollout Smooth?
2022-03-16
Moderna Unveils Three New mRNA Vaccine Programs
2022-02-21
Bioplus Interphex 2021: CDMOs- The Manufacturing Hub for the Next Generation of Therapeutics
2021-11-30
Sanofi Bets on Baidu’s Algorithm to Develop mRNA-Based Therapeutics
2021-11-23
1 2 3
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top